1. OC-016 Elevated Faecal Calprotectin Predicts Disease Progression in Crohn'S Disease. (4th June 2013) Authors: Kennedy, N A; Chang, J; Guy, M H; Smith, T; Loh, J T; Haunschmidt, D; Muscat, M; Spurio, F Fasci; Drummond, H E; Kingstone, K; Noble, C L; Shand, A G; Satsangi, J; Arnott, I D; Lees, C W Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTU-072 Discontinuation of Infliximab in Patients with Ulcerative Colitis is Associated with Increased Risk of Relapse: A Multinational Retrospective Cohort Study. (17th August 2016) Authors: Fiorino, G; Cortes, PN; Ellul, P; Felice, C; Karatzas, P; Silva, M; Lakatos, PL; Bossa, F; Sebastian, S; Ungar, B; Furfaro, F; Karmiris, K; Katsanos, KH; Muscat, M; Christodoulou, D; Maconi, G; Kopylov, U; Magro, F; Mantzaris, GJ; Armuzzi, A Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PWE-094 The Prevalence of Anaemia in Inflammatory Bowel Disease in Relation to Disease Activity, as Stratified by Faecal Calprotectin. (4th June 2013) Authors: Muscat, M; Kennedy, N A; Chang, J; Satsangi, J; Arnott, I D; Kingstone, K; Lees, C W Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗